MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$189,948K
Net Income
$14,682K
Net Profit Margin
7.73%
EPS
$0.41
Unit: Thousand (K) dollars
Revenue Breakdown
Product
Service
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
189,948
173,933
160,764
143,823
Product
25,566
24,308
23,402
18,687
Service
51,184
48,464
43,948
40,561
Total cost of revenue
76,750
72,772
67,350
59,248
Gross profit
113,198
101,161
93,414
84,575
Research, development and clinical trials
31,632
24,879
20,701
15,260
Selling, general and administrative
57,830
62,985
51,440
46,015
Total operating expenses
89,462
87,864
72,141
61,275
Income from operations
23,736
13,297
21,273
23,300
Interest expense
7,225
7,170
3,354
3,491
Interest income and other income (expense), net
2,894
2,358
3,714
3,222
Total other expense, net
-4,331
-4,812
360
-269
Income before income taxes
19,405
8,485
21,633
23,031
Provision for income taxes
4,723
1,170
-83,750
-1,288
Net income
14,682
7,315
105,383
24,319
Basic EPS
0.42
0.21
3.079
0.71
Diluted EPS
0.41
0.2
2.574
0.66
Basic Average Shares
34,579,980
34,384,207
34,227,148
34,112,452
Diluted Average Shares
40,709,227
36,194,023
40,941,313
40,748,023
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Product
$111,158K
(15.67%↑ Y/Y)
Service
$78,790K
(28.59%↑ Y/Y)
Total revenue
$189,948K
(20.70%↑ Y/Y)
Gross profit
$113,198K
(17.20%↑ Y/Y)
Total cost of revenue
$76,750K
(26.27%↑ Y/Y)
Income from operations
$23,736K
(-35.09%↓ Y/Y)
Total operating
expenses
$89,462K
(49.05%↑ Y/Y)
Service
$51,184K
(23.75%↑ Y/Y)
Product
$25,566K
(31.64%↑ Y/Y)
Income before income
taxes
$19,405K
(-46.37%↓ Y/Y)
Total other expense,
net
-$4,331K
(-1024.94%↓ Y/Y)
Interest income and other
income (expense), net
$2,894K
(-6.37%↓ Y/Y)
Selling, general and
administrative
$57,830K
(31.17%↑ Y/Y)
Research, development and
clinical trials
$31,632K
(98.52%↑ Y/Y)
Net income
$14,682K
(-57.94%↓ Y/Y)
Provision for income taxes
$4,723K
(270.43%↑ Y/Y)
Interest expense
$7,225K
(107.85%↑ Y/Y)
Buy us a coffee
TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. (TMDX)